Overall rank by patents
#4,375
Across all tracked assignees
USPTO PatentsView assignee record - 81 granted patents across 83 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01T (MEASUREMENT OF NUCLEAR OR X-RADIATION).
The verdict
Consolidated holds 81 US patents across 83 technology areas, rank #4,375 of 50,000 tracked assignees.
Consolidated Nuclear Security, Llc has been granted 81 US utility patents between 2015 and 2025, placing Consolidated Nuclear Security, Llc at rank #4,375 across all assignees tracked by PlainPatent. This portfolio spans 83 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in G01T (MEASUREMENT OF NUCLEAR OR X-RADIATION). As a US Corporation, Consolidated Nuclear Security, Llc is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Consolidated sits between Clearsign Combustion Corporation (81 patents, rank #4,371) and Friedrich-alexander-universität Erlangen-nürnberg (81 patents, rank #4,379) - the closest US assignees by grant volume. The composite Innovation Score of 58.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 37 grants, compared with 44 in the 2015–2019 window, a -16% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Consolidated Nuclear Security, Llc's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 83 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Consolidated Nuclear Security, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CLEARSIGN COMBUSTION CORPORATION
81 patents
CLEMSON UNIVERSITY RESEARCH FOUNDATION
81 patents
CVDevices, LLC
81 patents
Children's Healthcare of Atlanta
81 patents
DINKLE ENTERPRISE CO., LTD.
81 patents
ECO Holding 1 GmbH
81 patents
Eagle Harbor Technologies, Inc.
81 patents
FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG
81 patents
Consolidated Nuclear Security, LLC
81 patents
What this shows Consolidated holds 81 patents at rank #4,375, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,375 in granted patent volume.
Other assignees with the most granted patents in Consolidated's primary technology class.
Consolidated's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
59 Top 4% higher than 96% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 13 | 16.0% |
| 2016 | 8 | 9.9% |
| 2017 | 7 | 8.6% |
| 2018 | 12 | 14.8% |
| 2019 | 4 | 4.9% |
| 2020 | 7 | 8.6% |
| 2021 | 5 | 6.2% |
| 2022 | 9 | 11.1% |
| 2023 | 10 | 12.3% |
| 2024 | 2 | 2.5% |
| 2025 | 4 | 4.9% |
Top 15 of 83 technology areas
Overall rank by patents
#4,375
Across all tracked assignees
58.7 out of 100
How to use this portfolio
Consolidated's 81 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.